Primary Vaccination Course in Healthy Children Receiving the Pneumococcal Vaccine GSK 1024850A Co-administered With Tritanrix-HepB/Hib at 6, 10 and 14 Weeks of Age.

Trial Profile

Primary Vaccination Course in Healthy Children Receiving the Pneumococcal Vaccine GSK 1024850A Co-administered With Tritanrix-HepB/Hib at 6, 10 and 14 Weeks of Age.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; DTP-hepatitis B vaccine; Hib vaccine conjugate; Hib-DTP hepatitis B vaccine (Tritanrix-HepB/Hiberix)
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Pneumococcal infections; Tetanus
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 21 Jan 2011 New source identified and integrated (Clinical Trials Registry - India).
    • 21 Jan 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 28 Apr 2010 Planned end date changed from 1 Oct 2009 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top